Phase III trial of adjuvant 13-cis-retinoic acid and interferon-alpha for patients with aggressive skin squamous cell carcinoma.

被引：0
|
作者：
Brewster, Abenaa M.
Lee, J. Jack
Clayman, Gary
Clifford, John
Reyes, Mary Jo Necesito
Zhou, Xian
Sabichi, Anita
Strom, Sara
Collins, Robert
Meyers, Christina
Lippman, Scott
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
[2] LSU Hlth Sci Ctr, Shreveport, LA USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5659
引用
收藏
页数：2
相关论文
共 50 条
  • [21] 13-Cis-retinoic acid with alpha-2a-interferon enhances radiation cytotoxicity in head and neck squamous cell carcinoma in vitro
    DeLaney, TF
    Afridi, N
    Taghian, AG
    Sanders, DA
    Fuleihan, NS
    Faller, DV
    Nogueira, CP
    CANCER RESEARCH, 1996, 56 (10) : 2277 - 2280
  • [22] 13-CIS-RETINOIC ACID PLUS INTERFERON-ALPHA IN SOLID TUMORS - KEEPING THE CART BEHIND THE HORSE
    LIPPMAN, SM
    HONG, WK
    ANNALS OF ONCOLOGY, 1994, 5 (05) : 391 - 393
  • [23] Interferon alpha-2a and 13-cis-retinoic acid in patients with metastatic renal cell cancer
    Jacobs, A
    Gold, P
    Weiden, P
    Aboulafia, D
    Rudolph, R
    Picozzi, V
    Thompson, J
    CANCER INVESTIGATION, 2000, 18 (05) : 417 - 421
  • [24] Phase II clinical trial of 13-cis-retinoic acid and interferon-α-2a in patients with advanced esophageal carcinoma
    Enzinger, PG
    Ilson, DH
    Saltz, LB
    Martin, LK
    Kelsen, DP
    CANCER, 1999, 85 (06) : 1213 - 1217
  • [25] A Phase II study of 13-cis-retinoic acid in patients with advanced renal cell carcinoma
    William J. Berg
    Lawrence H. Schwartz
    Alison Amsterdam
    Madhu Mazumdar
    Vaia Vlamis
    Teresa Murray Law
    David M. Nanus
    Robert J. Motzer
    Investigational New Drugs, 1997, 15 : 353 - 355
  • [26] A Phase II study of 13-cis-retinoic acid in patients with advanced renal cell carcinoma
    Berg, WJ
    Schwartz, LH
    Amsterdam, A
    Mazumdar, M
    Vlamis, V
    Law, TM
    Nanus, DM
    Motzer, RJ
    INVESTIGATIONAL NEW DRUGS, 1997, 15 (04) : 353 - 355
  • [27] Combined interferon-alfa, 13-cis-retinoic acid, and alpha-tocopherol in locally advanced head and neck squamous cell carcinoma:: Novel bioadjuvant phase II trial
    Shin, DM
    Khuri, FR
    Murphy, B
    Garden, AS
    Clayman, G
    Francisco, M
    Liu, D
    Glisson, BS
    Ginsberg, L
    Papadimitrakopoulou, V
    Myers, J
    Morrison, W
    Gillenwater, A
    Ang, KK
    Lippman, SM
    Goepfert, H
    Hong, WK
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (12) : 3010 - 3017
  • [28] Effect of 13-cis-retinoic acid with neoadjuvant chemotherapy in patients with squamous cervical carcinoma
    Kim, JW
    Kim, YT
    Choi, SM
    Kim, DK
    Song, CH
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (05): : 442 - 444
  • [29] A TRIAL OF 13-CIS-RETINOIC ACID FOR TREATMENT OF SQUAMOUS-CELL CARCINOMA AND PRENEOPLASTIC LESIONS OF THE HEAD IN CATS
    EVANS, AG
    MADEWELL, BR
    STANNARD, AA
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 1985, 46 (12) : 2553 - 2557
  • [30] A phase I trial of weekly paclitaxel, 13-cis-retinoic acid, and interferon alpha in patients with prostate cancer and other advanced malignancies
    Thalasila, A
    Poplin, E
    Shih, J
    Dvorzhinski, D
    Capanna, T
    Doyle-Lindrud, S
    Beers, S
    Goodin, S
    Rubin, E
    DiPaola, RS
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 52 (02) : 119 - 124
12345